Pharmaceutical news

TRACON Pharmaceutical (TCON) Announces Positive Results Based on Double-Digit Objective Response Rate in Each Cohort from the Ongoing ENVASARC Phase 2 Pivotal Trial - StreetInsider.com

External page is loading, the page should display in a few seconds..

    Follow @Pharma_NewsUS on Twitter!